Memed raises BRL 80 million Series B+ round led by DGF and Bridge One

BZCP - Bronstein, Zilberberg, Chueiri e Potenza Advogados advised Memed, a digital prescription and digital health infrastructure platform, in its Series B+ funding round led by DGF, Bridge One, and with participation from DNA Capital. The financing will be allocated to the integration of artificial intelligence into the clinical prescription process.